The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors.
 
Benedito A. Carneiro
Consulting or Advisory Role - EMD Serono; Foundation Medicine; Tempus
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Pfizer (Inst)
 
Ludimila Cavalcante
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics; MorphoSys
 
Bruno R. Bastos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Actuate Therapeutics (Inst); Altor BioScience (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Tolero Pharmaceuticals (Inst); US Oncology (Inst)
 
Steven Francis Powell
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Actuate Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Vyriad (Inst)
 
Wen Wee Ma
Research Funding - Actuate Therapeutics (Inst); Athenex (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merrimack (Inst)
 
Solmaz Sahebjam
Stock and Other Ownership Interests - Allergan
Research Funding - Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Lilly
 
Donald Harvey
No Relationships to Disclose
 
Andre Luiz De Souza
No Relationships to Disclose
 
Mallika Sachdev Dhawan
No Relationships to Disclose
 
Howard Safran
No Relationships to Disclose
 
Francis J. Giles
Employment - Actuate Therapeutics
Leadership - Epigene Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
 
Pamela N. Munster
Leadership - Alessa Therapeutics
Stock and Other Ownership Interests - Alessa Therapeutics
Honoraria - AtlasMedx; Celgene; CStone Pharmaceuticals; Epigene; McVeigh; Prometheus (I); Xynomic Pharma (Inst)
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UCSF patent on using silastic implants to deliver anticancer agents